Table 6

Influence of disease characteristics on relapse in patients with nonseminomas
Variables No. Relapse Univariate analyses
n (%) p HR 95% CI
Age <40 30 7 (23.3%) 0.92 1.08 0.23-5.21
≥40 10 2 (20.0%) 1
Tumor size ≤5 cm 22 5 (22.7%) 0.88 0.90 0.21-3.75
>5 cm 12 3 (25.0%) 1
Embryonal carcinoma No 11 4 (36.4%) 0.21 2.31 0.62-8.60
Yes 28 5 (17.9%) 1
Choriocarcinoma No 32 8 (25.0%) 0.57 1.83 0.23-14.7
Yes 7 1 (14.3%) 1
Teratoma No 17 3 (17.6%) 0.49 0.62 0.15-2.46
Yes 22 6 (27.3%) 1
Yalk sac tumor No 19 3 (15.8%) 0.33 0.50 0.13-2.01
Yes 21 6 (28.6%) 1
AFP Normal 8 2 (25.0%) 0.93 0.93 0.19-4.49
Elevated 29 7 (24.1%) 1
βhCG Normal 13 4 (30.8%) 0.64 1.37 0.37-5.10
Elevated 23 5 (21.7%) 1
LDH Normal 20 6 (30.0%) 0.49 1.63 0.41-6.51
Elevated 16 3 (18.8%) 1
pT T1 16 3 (18.8%) 0.19 0.39 0.10-1.58
T2-4 15 6 (40.0%) 1
Lymphovascular invasion No 16 3 (18.8%) 0.19 0.39 0.10-1.58
Yes 15 6 (40.0%) 1

LDH, lactate dehydrogenase; AFP, α-fetoprotein, hCGβ, human chorionic gonadotropin β subunit.

Kobayashi et al.

Kobayashi et al. Diagnostic Pathology 2013 8:57   doi:10.1186/1746-1596-8-57

Open Data